Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 9,450.00
-400.00 (-4.06%)
Sep 17, 2026, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 683.63 billion as of September 16, 2026. Its market cap has increased by 37.96% in one year.
Market Cap
683.63B
Enterprise Value
700.08B
Revenue
53.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,450.00
ChartMarket Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 683.63B, an increase of 625.25%. That is a compound annual growth rate of 8.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 683.63B | 34.85% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.37T |
| Orum Therapeutics | 1.10T |
| Chabiotech | 724.29B |
| Onconic Therapeutics | 662.95B |
| Hyundai Bioscience | 657.19B |
| Pharmicell | 651.64B |
| GI Innovation | 590.32B |
| Medy-Tox | 437.87B |